Fox News |
Panel recommends Lilly continue breast cancer drug study
Fox News Eli Lilly and Co said an interim analysis of a late-stage study testing its breast cancer drug abemaciclib by an independent panel showed the treatment did not meet the effectiveness criteria and recommended that the company continue the trial. The ... Lilly Provides Update on MONARCH 2 Phase 3 Trial of Abemaciclib |
Panel recommends Lilly continue breast cancer drug study - Fox News
Read More
0 Response to "Panel recommends Lilly continue breast cancer drug study - Fox News"
Post a Comment